Key Highlights

• Medication-Assisted Treatment (MAT) is an evidence-based method for treating substance use disorder in prisons.
• The use of MAT for addiction helps manage opioid use disorders by treating them as chronic illnesses.
• MAT injection programs use FDA-approved medications like Naltrexone, Methadone, and Buprenorphine.
• These programs improve health outcomes and reduce the chances of relapse after release.
• MAT provides a structured path to recovery for incarcerated individuals struggling with substance abuse.
• Successful implementation involves partnerships and dedicated staff training.

Introduction

Tackling substance abuse within the correctional system is a critical challenge across the United States. A modern and effective approach gaining traction is the Medication-Assisted Treatment (MAT) program. This method offers a new perspective on treating individuals with opioid use disorders during incarceration. By combining medication with behavioral therapies, MAT provides a comprehensive strategy that supports long-term recovery, viewing addiction not as a moral failing but as a treatable chronic disease. This shift in approach is making a significant difference.

Overview of MAT Injection Programs in U.S. Prisons

Across the United States, correctional facilities are increasingly adopting MAT programs to address the high rates of substance abuse among inmates. These programs are a pivotal part of the strategy supported by the Office of Justice Programs to combat the opioid crisis.

By providing medication in a controlled setting, these programs help stabilize individuals with opioid use disorders. This approach allows them to engage more effectively in behavioral therapies, preparing them for a healthier life after release. The following sections will explore what MAT involves and the medications used.

Defining Medication-Assisted Treatment (MAT) and Its Role in Corrections

Medication-Assisted Treatment (MAT) is a comprehensive, evidence-based approach that combines FDA-approved medications with counseling and behavioral therapies. Its purpose is to provide a “whole-patient” approach to the treatment of substance use disorder. In a correctional setting, MAT is a lifeline for individuals struggling with addiction.

The role of MAT is to treat addiction to opiates and other substances as a chronic disease rather than an acute illness. This perspective, supported by the Department of Justice, emphasizes long-term management and monitoring to produce lasting benefits. By stabilizing patients and reducing cravings, MAT helps create a foundation for recovery.

Instead of a short-term fix, these programs offer sustained support. This helps incarcerated individuals manage their addiction, participate in rehabilitation, and prepare for successful reentry into the community, ultimately breaking the cycle of substance use and re-incarceration.

Types of Medications Used and the MAT Injection Process

The effectiveness of a MAT program hinges on the use of specific, FDA-approved medications that are proven to help manage substance use disorders. These medications work by normalizing brain chemistry, blocking the euphoric effects of alcohol and opioids, relieving cravings, and normalizing body functions without the negative effects of the abused drug.

Correctional facilities utilize several key medications as part of their MAT programs. The primary options include:

• Naltrexone: An opioid antagonist that blocks the euphoric and sedative effects of opioids. It is available in oral and injectable forms.
• Buprenorphine: A partial opioid agonist that reduces cravings and withdrawal symptoms without producing a full “high.”
• Methadone: A long-acting full opioid agonist that helps individuals with opioid addiction manage their symptoms.

The MAT injection process involves administering these medications under the supervision of healthcare professionals within the facility. This ensures proper dosage and adherence, providing a safe and structured environment for treatment.

Operational Workflow and Implementation in Correctional Facilities

Implementing a MAT program within correctional facilities requires a structured and well-defined operational workflow. Guidance from entities like the Office of Justice Programs and the Department of Justice helps ensure these programs are safe, effective, and compliant with best practices.

The goal is to create a seamless process from inmate intake to continued care. This involves initial screening, treatment administration, and planning for post-release support. Let’s look at the specific steps and partnerships that make these programs work.

Steps in Administering the MAT Injection Program

A successful MAT injection process follows a clear operational workflow to ensure consistency and safety. It begins the moment an individual with a history of substance abuse enters the facility. Trained correctional and healthcare staff work together to manage each step carefully.

This structured approach ensures that every participant receives consistent and appropriate care throughout their time in the facility. The process is designed to be both therapeutic and secure. Below is a simplified look at the key stages involved.

Step	Action
Intake & Screening	New inmates are assessed for substance use disorder history. Those already on a verified community MAT program may continue treatment.
Eligibility Review	A healthcare team reviews each case to confirm the individual meets the criteria for the MAT program.
Treatment Initiation	Eligible inmates begin their prescribed medication, such as Suboxone or Naltrexone, administered by medical staff.
Ongoing Management	Participants receive regular medication, counseling, and behavioral therapy as part of a comprehensive treatment plan.
Reentry Planning	Before release, staff work to connect the individual with community-based MAT providers to ensure continuity of care.

Partnership Programs and Staff Training for Successful Delivery

Successful MAT programs don’t operate in a vacuum. They rely on strong partnership models and consistent staff training, especially in correctional settings where care delivery is complex. Integrating physician-led telehealth support such as the services provided by DevotedDOc helps facilities uphold evidence-based standards while expanding access to clinical expertise. Collaboration between correctional teams, community treatment partners, and external organizations ensures that individuals with opioid use disorder receive safe, research-aligned care from intake through reentry.

The Department of Justice and the Office of Justice Programs frequently support these partnerships by offering guidance, technical resources, and national best-practice frameworks. These agencies reinforce the importance of aligning MAT protocols with modern addiction medicine. When facilities pair federal guidance with the operational support of telehealth partners like DevotedDOc, they create a more stable and compliant foundation for treatment delivery.

Key components for successful MAT implementation include:

• Collaborative Efforts: Coordinating with federal agencies, professional associations, and community or telemedicine healthcare providers ensures alignment with current research, clinical standards, and operational best practices.
• Staff Training: All personnel from correctional officers to health services staff should receive training on addiction science, MAT workflows, diversion prevention, and safety procedures. Structured support from physician-led partners strengthens consistency and confidence across teams.
• Continuous Improvement: Reviewing model programs, participating in round tables, and adopting lessons learned from other jurisdictions helps facilities refine their approaches, resolve implementation challenges, and strengthen continuity of care.

This collaborative framework makes MAT programs more resilient and effective. It ensures staff are better prepared, workflows remain secure, and individuals in custody receive care that is both clinically sound and supportive of long-term recovery.

Eligibility and Access to Prison-Based MAT Programs

Determining who can participate in a prison-based MAT program is a critical step. Eligibility generally hinges on a confirmed diagnosis of opioid use disorder along with an assessment of clinical and safety-related risk factors. The aim is to identify individuals who are most likely to benefit from evidence-based treatment and who would face heightened health risks without it. Many facilities now collaborate with physician-led telehealth partners like DevotedDOc to support accurate diagnosis, standardized screening, and consistent clinical decision-making.

Facilities must also balance access to care with overarching security and operational needs. As MAT programs demonstrate strong outcomes such as reduced withdrawal complications, improved stability, and safer reentry transitions correctional systems nationwide are finding ways to broaden availability for individuals who need treatment. The next sections will outline the criteria commonly used for participation and explain how access continues to expand across different types of facilities.

Criteria for Inmate Participation

The criteria for eligibility in a prison MAT program are specific and carefully considered. A primary factor is whether an inmate was already enrolled in a verified MAT program in the community or a county jail upon intake. In many cases, these individuals are allowed to continue their treatment seamlessly.

For others, eligibility is determined through a screening process that confirms a diagnosis of a moderate to severe substance use disorder, particularly for opioids. Healthcare staff review the individual’s medical and substance use history to identify key risk factors and determine if MAT is the appropriate clinical path.

The Department of Justice provides guidelines, but final decisions are often made by the facility’s healthcare services bureau on a case-by-case basis. This ensures that treatment is tailored to the individual’s specific needs while maintaining the safety and security of the institution.

How Facilities Determine and Expand Access

The decision to implement or expand a MAT program within a correctional facility is often driven by proven success and demonstrated need. Program expansion typically follows a phased approach, starting with a pilot and growing as positive outcomes are documented.

Facilities evaluate several factors to determine how to broaden access to the general population struggling with substance abuse. Key considerations include:

• Program Success: Analyzing data on relapse rates, health outcomes, and recidivism from existing programs.
• Identified Need: Assessing the prevalence of substance use disorder within the inmate population to justify expansion.
• Resource Availability: Ensuring the operational workflow can support more participants, including staffing, medication supply, and security protocols.

While not yet available in all U.S. prisons, the goal is to continue increasing program availability. The success of early programs, like the one started at SCI Muncy in 2014, serves as a model for other facilities looking to combat substance abuse effectively and improve long-term outcomes for inmates.

Key Benefits and Outcomes of Prison MAT Injection Programs

The implementation of MAT programs in prisons yields significant benefits, not just for the individuals involved but for the community as a whole. By treating opioid use disorders and other forms of substance abuse as chronic health conditions, these programs foster genuine recovery.

The positive outcomes are clear, ranging from lower relapse rates post-release to broader public health benefits. Let’s examine how these programs directly impact an individual’s recovery journey and contribute to a healthier society.

Impact on Relapse Rates Post-Release

One of the most significant benefits of prison-based MAT programs is their direct impact on reducing relapse rates after an individual is released. The period immediately following release is incredibly vulnerable for those with a history of substance abuse, with a high risk of overdose and a return to drug use.

MAT provides a crucial bridge during this transition. By managing cravings and withdrawal symptoms, the medication allows individuals to focus on rebuilding their lives without the constant pressure of addiction. When combined with evidence-based behavioural therapy, it equips them with the coping skills needed to navigate challenges outside of prison.

Research and program results consistently show that individuals who participate in MAT during incarceration have substantially lower relapse rates. This success underscores the importance of treating opioid use disorders with a long-term, medically supported management strategy rather than expecting abstinence alone to be sufficient.

Enhanced Recovery and Public Health Benefits

Beyond reducing relapse, MAT programs offer a wide array of benefits that enhance individual recovery and promote public health. Treating substance abuse within the correctional system creates a ripple effect of positive change that extends far beyond prison walls.

By addressing the root causes of addiction in a therapeutic environment, these programs help break the cycle of crime and incarceration associated with substance use disorders. The broader public health benefits are substantial and multifaceted. These include:

• Improved medical and mental health outcomes for participants.
• Reduced rates of recidivism, as stable individuals are less likely to reoffend.
• Lowered risk of transmitting infectious diseases associated with IV drug use.
• A healthier and more productive community as individuals successfully reintegrate.

Ultimately, viewing and treating addiction as a chronic illness within prisons is a smart public health strategy. It saves lives, reduces crime, and builds stronger communities.

Conclusion

In conclusion, the MAT injection program in prisons plays a vital role in transforming the lives of incarcerated individuals who are managing opioid use disorder. By offering evidence-based medication-assisted treatment, these programs reduce relapse risk after release and contribute meaningfully to broader public health and community safety. Having a clear understanding of the operational workflow and eligibility criteria allows facilities to implement MAT more effectively and sustainably. As correctional systems continue building comprehensive treatment frameworks, it becomes increasingly important to recognize how these initiatives support recovery, reduce harm, and strengthen successful reintegration. If your county, jail, or DOC team is exploring MAT partnerships, DevotedDOc provides physician-led telehealth support across Florida, Georgia, Oklahoma, New Mexico, and additional states as programs expand. Reach out anytime to discuss how a coordinated partnership can help your facility strengthen continuity of care and build a safer, more clinically sound MAT program.

Frequently Asked Questions